Archive for April, 2019
VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF), a leading provider of premium cannabis products and services for the medical and adult-use markets and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited, Abcann Medicinals Inc. and Harvest Medicine Inc., this morning announced the release of its Q4 and 2018 annual financial and operating results. “The VIVO team achieved significant milestones in 2018, leading to substantial increases in net revenue, cash position, production capacity, organizational effectiveness and customer development,” VIVO CEO Barry Fishman said in the news release. “The strategic acquisitions of Canna Farms and Harvest Medicine were important drivers of our improved financial results. Through the acquisition of Canna Farms, we have added an award-winning BC craft brand, are leveraging best practices, and have dramatically increased capacity. Harvest Medicine provides a scalable network of medical cannabis clinics offering industry-leading patient care and access to critical data to shape our innovative product development efforts. VIVO remains committed to changing the way people view cannabis and to ensuring medical patients and adult-use consumers have access to our premium cannabis products and services.”
To view the full press release, visit: http://nnw.fm/uE7t7
About VIVO Cannabis(TM)
VIVO Cannabis(TM), based in Napanee, Ontario, is recognized for trusted, high-quality products and services. It holds production and sales licenses from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical(TM), FIRESIDE(TM), Canna Farms(TM) and Lumina(TM). In August 2018, VIVO acquired Canna Farms, a premium cannabis company based in Hope, British Columbia. Canna Farms was B.C.’s first Licensed Producer and has several years of craft cultivation experience and expertise, as well as a significant patient base and positive cash flow. The Company is significantly expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, including Germany and Australia. VIVO also operates Harvest Medicine, a patient-centric and highly scalable network of specialty medical cannabis clinics as well as a free telemedicine app. VIVO has a healthy balance sheet and is well-positioned to accelerate its growth in Canada and internationally. For more information, visit the company’s website at www.VivoCannabis.com.
NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://nnw.fm/VVCIF
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
Vancouver, British Columbia–(April 30, 2019) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) applied for a permanent manufacturing, distribution and a transportation license this week with the city of Adelanto, CA.
“Our immediate focus is to be able to have our city and state licenses in place in Adelanto as soon as possible. Subsequent to the GoodFellas acquisition we will be able to prepare and package the Daily Cannabis Brand pre-rolls at the facility and then deliver the products to the dispensaries without the need to bring in a third party,” stated Jim Pakulis, CEO of TransCanna.
“And as previously stated, the Daily Cannabis Brand has trended in percentage of sales increase since it began selling in the summer of 2018, and our goal is to provide not only the Daily Cannabis Brand with the necessary resources to continue and grow, but to use the Adelanto facility as the first TransCanna satellite distribution network facility throughout the state in an effort to provide reliability, consistency and quality to the dispensaries, and just as importantly scale TransCanna’s ecosystem as expeditiously as possible.”
The Company will provide an update later in the week as it relates to the licensing process for its 196,000 square foot facility in Modesto, CA.
For further information, please visit the Company’s website at www.transcanna.com.
About TransCanna Holdings Inc.
TransCanna Holdings Inc. is a Canadian-based company focused on providing integrated branding, transportation and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace.
For further information, please visit the Company’s website at www.transcanna.com or email the Company at info@transcanna.com.
Media Contact
TransCanna@talkshopmedia.com
604-738-2220
On behalf of the Board of Directors
James Pakulis
Chief Executive Officer
Telephone: (604) 609-6199
The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Company believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cannabis-focused research and development company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) this morning announced that its Kelowna-based extraction processing services provider, Valens GroWorks Corp., has obtained its organic certification from Pro-Cert Organic Systems Ltd. “TGOD has been committed to organic since day one. Working with service providers who embrace organic as much as we do is paramount. I want to congratulate the team at Valens for obtaining their organic certification,” Brian Athaide, CEO of TGOD, stated in the news release. “We look forward to delivering certified organic oils of the highest standards to our patients and customers.” As per a previous announcement, TGOD will have exclusive access to Valens’ services for certified organic extraction processing for a period of one year.
To view the full press release, visit http://nnw.fm/fc5N0
About The Green Organic Dutchman Holdings Ltd.
The Green Organic Dutchman Holdings is a publicly traded, premium global organic cannabis company with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. The company grows high-quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned global capacity of 219,000 kgs. and is building 1,643,600 square feet of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark. For more information, visit the company’s website at www.TGOD.ca
NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://nnw.fm/TGODF
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
Aptito Becomes an HP Channel Partner for Sales and Support of HP POS Solutions
MIAMI, FL, April 30, 2019 — via NEWMEDIAWIRE – Net Element, Inc. (NASDAQ: NETE)(“Net Element” or the “Company”), a global technology and value-added solutions group that supports electronic payments acceptance in a multi-channel environment including point-of-sale (“POS”), today announces that its Aptito subsidiary has entered into a channel partner agreement with HP Inc. for sales and support of its line of Android-based POS devices.
The Electronic Transaction Association (“ETA”) Payments Trends to Watch report predicts that US merchants will spend nearly $2 billion on frictionless payment solutions such as technology-enabled integrated POS solutions (IPOS) in 2019, underscoring the value that advanced payments solutions provide to merchants and payment service providers. Net Element is poised to benefit as these merchants upgrade their traditional POS systems to user friendly IPOS solutions that inspire customer loyalty and maximize revenue potential.
According to the U.S. Small Business Administration there is an addressable market of an estimated 600,000 small and mid-sized businesses (SMBs) in the United States. Aptito’s goal is to provide its restaurant management software-as-a-service (SaaS) alongside HP’s POS solutions to offer SMBs cutting-edge technology and competitively priced value-added services backed by HP’s global sales and support. In addition, HP’s Android-based IPOS solutions come with a full suite of retail peripherals and accessories that can be used as tools for assisted selling and mobile transactions.
“We are excited to work with HP to deliver our SaaS in their IPOS solutions to our existing and new merchants worldwide,” commented Andrey Krotov, President of Aptito. “Aptito is currently deployed in 16 countries and growing, HP’s global sales and support provide a springboard for continued expansion.”
About Net Element
Net Element, Inc. (NASDAQ: NETE) operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the U.S. and selected emerging markets. In the U.S., the Company aims to grow transactional revenue by innovating SME productivity services using various technology solutions and Aptito, our cloud-based, restaurant and retail point-of-sale solution. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 and 2018 Technology Fast 500™. In 2017 we were recognized by South Florida Business Journal as one of 2016’s fastest-growing technology companies. Further information is available at www.NetElement.com.
Forward-Looking Statements
Securities Exchange Act of 1934, as amended. Any statements contained in this press release that are not statements of historical fact may be deemed forward-looking statements. Words such as “continue,” “will,” “may,” “could,” “should,” “expect,” “expected,” “plans,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” and similar expressions are intended to identify such forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of Net Element and are difficult to predict. Examples of such risks and uncertainties include whether the Company will benefit from any merchants who upgrade their traditional POS systems, whether Aptito will be successful in its restaurant management SaaS initiatives and whether the relationship will result in continued expansion for the Company. Further examples of such risks and uncertainties include but are not limited to (i) Net Element’s ability (or inability) to obtain additional financing in sufficient amounts or on acceptable terms when needed; (ii) Net Element’s ability to maintain existing, and secure additional, contracts with users of its payment processing services; (iii) Net Element’s ability to successfully expand in existing markets and enter new markets; (iv) Net Element’s ability to successfully manage and integrate any acquisitions of businesses, solutions or technologies; (v) unanticipated operating costs, transaction costs and actual or contingent liabilities; (vi) the ability to attract and retain qualified employees and key personnel; (vii) adverse effects of increased competition on Net Element’s business; (viii) changes in government licensing and regulation that may adversely affect Net Element’s business; (ix) the risk that changes in consumer behavior could adversely affect Net Element’s business; (x) Net Element’s ability to protect its intellectual property; (xi) local, industry and general business and economic conditions; and (xii) adverse effects of potentially deteriorating U.S.-Russia relations, including, without limitation, over a conflict related to Ukraine, including a risk of further U.S. government sanctions or other legal restrictions on U.S. businesses doing business in Russia. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements can be found in the most recent annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K filed by Net Element with the Securities and Exchange Commission. Net Element anticipates that subsequent events and developments may cause its plans, intentions and expectations to change. Net Element assumes no obligation, and it specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by law.
Contact:
Net Element, Inc.
+1 (786) 923-0502
www.NetElement.com
Media@NetElement.com
Corporate Communications Contact:
NetworkWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com
Los Angeles, California-based cannabis firm Cannabis Strategic Ventures (OTC: NUGS), through its diverse portfolio of subsidiaries, is focused on supporting entrepreneurial growth within the cannabis sector. An article discussing the company reads, “Thus far in 2019, NUGS has filed an application for uplisting to the OTCQB Venture Market; announced that it will partner with a Santa Barbara County cultivation operation that holds about 40 commercial cannabis licenses in Southern California; revealed that it will add a six-acre Northern California site to its holdings after having obtained over 20 licenses for cannabis manufacturing, distribution and cultivation there; and secured an investment of up to $3 million from student-led business Triton Funds subsequent to an upcoming S1 registration statement, which will allow Cannabis Strategic Ventures to accelerate its cultivation business priorities and the expansion of its existing portfolio brands.”
To view the full article, visit: http://nnw.fm/p4Uig
About Cannabis Strategic Ventures Inc.
Cannabis Strategic Ventures is a Los Angeles-based firm that incubates, develops and partners with category leaders within the cannabis sector. The firm’s NUGS brand experience provides mentorship and a range of essential services to emerging and existing cannabis consumer brands. The company recently completed a name and symbol change from Cascade Energy Inc. Cannabis Strategic Ventures is publicly traded on the U.S. Over-the-Counter Market with the stock symbol NUGS. For more information, visit the company’s website at www.CannabisStrategic.com.
NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://nnw.fm/NUGS
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
Biotechnology company and drug-delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed and out-licenses its pioneering-drug delivery platform DehydraTECH(TM), which improves the speed, taste and delivery of bioactive compounds, including nicotine and cannabinoids. A recent article discussing the company reads, “Furthermore, the DehydraTECH drug delivery platform increases bio-absorption by up to 10 times and lessens the time of onset, with effects being felt within 15 to 20 minutes, as compared to 60 to 120 minutes without the platform. In addition, the technology is patent protected for cannabidiol (CBD) and all other nonpsychoactive cannabinoids. Patents are also granted for THC (tetrahydrocannabinol), other psychoactive compounds and NSAIDs (nonsteroidal, anti-inflammatory drugs), as well as nicotine and other molecules. . . . Lexaria Bioscience has partnered with one of the world’s largest tobacco companies to fund the research and development of the DehydraTECH technology for oral nicotine. Through wholly owned subsidiary Lexaria Nicotine LLC, Lexaria is working to propel innovation in oral, reduced-risk nicotine consumer products utilizing DehydraTECH (http://nnw.fm/OmL1K).”
To view the full article, visit: http://nnw.fm/bSL9u
About Lexaria Bioscience Corp.
Lexaria Bioscience has developed and out-licenses its disruptive delivery technology, which promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the United States and Australia for utilization of its DehydraTECH delivery technology. Lexaria’s technology provides increases in intestinal absorption rates, more rapid delivery to the bloodstream, and important taste-masking benefits for orally administered bioactive molecules including cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. For more information, visit the company’s website at www.LexariaBioscience.com.
NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://nnw.fm/LXRP
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) on Thursday announced the expiration of its formal offer to acquire all of the issued and outstanding common shares of Aphria Inc. (TSX: APHA) (NYSE: APHA). According to the update, the company will not be taking up any Aphria shares as the offer conditions have not been met. As announced on April 15, 2019, Green Growth Brands and Aphria entered into an agreement to shorten the offer acceptance expiry time from 5:00 PM (Toronto time) on May 9, 2019 to 5:00 PM (Toronto time) on April 25, 2019. The company has determined not to extend the offer expiry date, and all Aphria shares tendered to the offer will be promptly returned to Aphria shareholders.
To view the full press release, visit: http://nnw.fm/4mQLW
About Green Growth Brands
Green Growth Brands creates remarkable experiences in cannabis and CBD, led by CEO Peter Horvath and a leadership team of consumer-focused retail experts. The company’s brands include CAMP, Seventh Sense Botanical Therapy, The+Source, Green Lily and Meri + Jayne, with a licensing agreement with the Greg Norman Brand. Already boasting the strongest sales per square feet in the cannabis industry, GGB is expanding its presence in Nevada, Massachusetts and Arizona with CBD presence at ShopSeventhSense.com, in malls across the country and at DSW shoe stores—and that’s just the beginning. For more information, visit the company’s website at www.GreenGrowthBrands.com.
NOTE TO INVESTORS: The latest news and updates relating to GGBXF are available in the company’s newsroom at http://nnw.fm/GGBXF
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
Coalition406, a new group in Montana, is planning to formulate a ballot measure so that residents can decide whether recreational marijuana should be legalized in the state during the 2020 elections.
In recent years, efforts to legalize adult-use marijuana have attracted growing support in the population. This support is buoyed by the increasing number of states that are either in the process or have already legalized recreational marijuana.
A poll conducted in February this year by researchers from the University of Montana found that 51 percent of all voters in the state support recreational cannabis legalization.
Coalition406 strongly believes that once recreational cannabis is legalized, thousands of people will be employed in the industry and the state will collect revenues that can help to fund education, healthcare and infrastructure projects.
Ted Dick, a campaign manager for Coalition406, announced that the group would sponsor a listening tour throughout the state in order to gather views from people regarding the plan to legalize recreational marijuana. “We want to hear from real Montanans,” he added.
Ted Dick isn’t new on the political landscape of Montana. Previously, he worked as the Executive Director of the Democratic Party in Montana. He therefore brings extensive experience in politics to this initiative to see recreational marijuana legalized.
If the initiative is to make its way onto the ballot in November 2020, at least 25,468 signatures of registered voters will have to be collected after the initiate gets the nod to proceed to the step of gathering signatures.
If the University of Montana poll is indicative of people’s current views in the state, Coalition406 will have to do a lot of work to convince more people to support the measure since the opinion poll shows that legalization currently enjoys a slim majority which can be swayed by those opposed to legalization.
Events in other states which have tried to legalize recreational marijuana also show that the objective is often easier to attain through a ballot than through legislative means.
For example, a law legalizing recreational marijuana was almost a foregone conclusion until voting on the bill was postponed after legislative leaders realized that not enough support existed in the New Jersey senate.
Similarly, the state budget was presented in New York State without including recreational marijuana, and that has cast doubt over plans to legalize recreational marijuana there during this legislative session.
Ballot measures therefore appear to be a better approach to take since the people are often ahead of their elected representatives in terms of voicing what they want. For this reason, VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) and Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) applaud Coalition406 for taking the initiative to involve voters directly in matters of legalizing recreational cannabis in Montana.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have a questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
TORONTO, April 26, 2019 – The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX: TGOD) (US: TGODF) is pleased to announce that its wholly owned subsidiary, HemPoland, has received organic certification from EKOGWARANCJA PTRE. This organic certification is provided by the Polish Center for Accreditation on authority from the Minister of Agriculture and Rural Development. HemPoland’s facilities, production processes and product offerings are now certified organic.
TGOD’s extraction and formulation of premium high-quality hemp oils from certified organic raw materials within Poland, sets the foundation for novel and proprietary products to be offered throughout Europe and global markets with official PL-EKO-01 EU certificates. TGOD’s newly certified facility expands its global reach for certified organic production.
“We are incredibly excited that HemPoland’s facilities, production and processes have received organic certification within Europe,” stated Brian Athaide, CEO of TGOD. “This is a major point of differentiation that offers consumers a premium experience. We are proud to continue to deliver and execute on our global organic strategy.”
EKOGWARANCJA PTRE is the largest certification body supported by the Polish Ministry of Agriculture and Rural Development, certifying operators whose goods are being produced in accordance with council regulations.
On Behalf of the Board of Directors,
The Green Organic Dutchman Holdings Ltd.
About The Green Organic Dutchman Holdings Ltd.
The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) is a publicly traded, premium global organic cannabis company, with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned capacity of 219,000 kgs and is building 1,643,600 sq. ft. of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark.
TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively.
For more information on The Green Organic Dutchman Holdings Ltd., please visit www.tgod.ca.
Forward-Looking Information Cautionary Statement
This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward looking statements in this release includes, but is not limited to, statements about future research, development and innovation by the Company, statements about delivery of product, statements about future production and supply, statements about hemp production and product offerings, statements about the offering of any particular products by the Company in any jurisdiction and statements regarding the future performance of the Company. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accept responsibility for the adequacy or accuracy of this release.
- Q4 2018 Total Revenue Increases 37% over Q4 2017, Setting New Record Quarterly High;
- FY 2018 Total Revenue Increases 10% over FY 2017, Setting New Record Annual High;
- Initial Revenue Reported from New BioPharma Services and UST Businesses;
- Balance Sheet Improves with Significant Conversion of Debt to Equity.
- Investor Conference Call Scheduled for Thursday, April 25, 2019 at 4:30 PM EDT
SOUTH EASTON, MA / April 25, 2019 / Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments and related consumables for the worldwide life sciences and other industries, today announced financial results for the fourth quarter and fiscal year ended December 31, 2018, provided a business update, and offered limited guidance for FY2019.
Financial Results: Q4 2018 vs. Q4 2017
Total revenue for Q4 2018 was $686,558 compared to $502,708 for the same period in 2017, a 37% increase. This increase was primarily due to our double-digit growth in products and services and in grant revenues.
Products and services revenue was $535,860 for the fourth quarter of 2018 compared to $455,767 for the same quarter of 2017, an 18% increase. Sales of instruments increased to $388,356 in Q4 2018 compared to $317,498 in Q4 2017, an increase of 22%. Sales of consumables were $52,935 for 2018 fourth quarter compared to $60,108 for the same period in 2017, a 12% decrease. Grant revenue in Q4 2018 was $150,698 compared to $46,941 in Q4 2016 an increase of 321%.
Operating loss for Q4 2018 was $1,514,730 compared to $1,318,384 for the same period in 2017. This increase in operating loss was primarily due to increases in general and administrative expense.
Loss per common share – basic and diluted – was $(2.93) for Q4 2018 compared to $(2.37) for the same period in 2017.
Financial Results: FY2018 vs. FY2017
Total revenue for FY2018 was $2,457,871 compared to $2,240,498 for FY2017, a 10% increase. This increase was primarily due to our growth in products and services and in grant revenues.
Products and services revenue was $2,200,539 for the year ended December 31, 2018 compared with $2,065,891 for the year ended December 31, 2017, a 7% increase. Sales of instruments decreased to $1,418,731 for FY2018 compared to $1,459,326 for FY2017, a decrease of 3%. Sales of consumables were $235,132 for the year ended December 31, 2018 compared to $260,331 for the same period in 2017, a decrease of $25,199 or 10%. Grant revenue for fiscal year 2018 was $257,332 compared to $174,607 for the 2017 fiscal year, an increase of $82,725 or 48%.
Operating loss for FY2018 was $4,477,083 compared to $4,647,048 for FY2017. This decrease was primarily due to increases in total revenue.
Loss per common share – basic and diluted – was $(15.33) for FY2018 and $(9.62) for the 2017 fiscal year.
Operational & Technical Highlights: FY2018
- Bradford A. Young, Ph.D., MBA Joins PBI as Senior VP and Chief Commercial Officer in November 2018.
- We Converted $13.6 Million of Debt into Equity, Significantly Reducing Total Liabilities.
- A Major Cancer Research Center Reported that Our Patented Pressure Cycling Technology (“PCT”) Platform Could Play Major Role in Improving Cancer Diagnosis and Treatment.
- PBI and ISS, Inc. Announced Two-Year Worldwide Co-Marketing and Distribution Agreement.
- We were Awarded a Key U.S. Patent for Novel High-Pressure Flow-Through Microfluidic Sample Prep Device.
- Our Ultra High-Pressure Instruments, Processing Methods, and Platform Technologies were Prominently Featured at a Leading, Worldwide Food Science Meeting.
- We Announced the First Contract Utilizing our Recently Acquired, Patented Protein Refolding and Disaggregation Platform Technology from our December 2017 Purchase of All Assets of BaroFold, Inc.
- We Accelerated the Development of our Novel Ultra Shear Technology™ (“UST™”) Platform to Pursue Commercialization into Major New Markets, Including Food & Beverages, Nutraceuticals, and Cosmetics.
- Our Patented UST Platform was Featured as a Potential Breakthrough Processing Method for Higher Quality, Longer Lasting Liquid Foods and Beverages not requiring Refrigeration or Chemical Additives, such as Shelf Stable Milk and Other Dairy Products.
- We Announced a Strategic Collaboration with Ohio State’s College of Food, Agriculture, and Environmental Sciences, and were Awarded $318,000 from a USDA Grant to Build the First Prototype UST Instrument.
- We Achieved Two Major Milestones in the Development of our Proprietary UST Technology Platform, Including the Development of a UST-based Process to Make Nanoemulsions of CBD Plant Oil from Hemp.
Mr. Richard T. Schumacher, President and CEO of PBI, said: “This past year was filled with multiple significant financial, operational and technological accomplishments. Key among these was the hiring of Dr. Brad Young as PBI’s Chief Commercial Officer. In this leadership role, Dr. Young will be responsible for assessing multiple major new and divergent market opportunities, and for optimizing the commercialization priorities and strategy for PBI. In addition to this essential role in strategic planning, Dr. Young will also drive the execution of critical partnering and commercialization programs to build customer adoption and accelerate growth.”
Dr. Bradford A. Young, Chief Commercial Officer of PBI, commented: “We are pleased with the overall performance of the Company in 2018, especially in Q4 when total revenue reached a record, all-time high for quarterly revenue. In addition to recording significantly increased sales of our core, PCT platform in 2018, we also recorded the first revenue from our newly launched BioPharma Services business. Our BioPharma Services business helps us not only monetize the BaroFold assets we acquired in December 2017 for improved manufacturing of protein therapeutics, but also supports sales of our Barocycler PCT platform. In fact, we use the Barocycler 2320 EXTREME to perform our BioPharma Services and saw increased demand for our Barocycler 2320 EXTREME in 2018 for quality control applications used during the manufacturing of protein therapeutics.”
Dr. Young continued: “It’s clear that our PCT and BaroFold platform technologies can help companies produce new and improved therapeutic products, a market that is expected to reach $240 billion dollars by 2023 (ResearchAndMarkets.com, 2018). In addition, the new, cutting-edge Ultra Shear Technology (UST) platform we are developing for the production of high-quality nanoemulsion mixtures of oil & water can provide an enhanced way to deliver therapeutics or drugs. Thus, our UST platform has the potential to provide a superior method to develop and deliver drug formulations with improved bio-absorption and faster uptake. We look forward to building on the great progress we’ve made in 2018 and growing the adoption of our life sciences platform technologies for research, development and manufacturing applications in 2019 and beyond.”
Earnings Call
The Company will hold an Earnings Conference Call at 4:30 PM EDT on Thursday, April 25, 2019. To attend this teleconference via telephone, Dial-in: (844) 602-0380 (North America), (862) 298-0970 (International). Verbal Passcode: PBIO Fourth Quarter and Fiscal Year 2018 Financial Call. Replay Number (877) 481-4010; (919) 882-2331 (International). Replay Passcode: 47337. Teleconference Replay Available for 30 days.
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired protein disaggregation and refolding technology from BaroFold, Inc. (the “BaroFold” technology) to allow entry into the biologics contract research services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology™ (“UST™”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.
Forward Looking Statements
This press release contains forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed, implied or inferred by these forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “could,” “would,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “predicts,” “projects,” “potential” or “continue” or the negative of such terms and other comparable terminology. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. In evaluating these statements, you should specifically consider various factors. Actual events or results may differ materially. The Company’s financial results for the year ended December 31, 2018 may not necessarily be indicative of future results. These and other factors may cause our actual results to differ materially from any forward-looking statement. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.
For more information about PBI and this press release, please click on the following website link:
http://www.pressurebiosciences.com
Please visit us on Facebook, LinkedIn, and Twitter.
Investor Contacts:
Richard T. Schumacher, President and CEO
(508) 230-1828 (T)
Bradford A. Young, Ph.D., MBA, SVP and CCO
(508) 230-1829 (F)
PRESSURE BIOSCIENCES, INC. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF OPERATIONS
|
|
For the Three Months Ended
|
|
|
For the Year Ended
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
2018
|
|
|
2017
|
|
|
2018
|
|
|
2017
|
|
Revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Products, services, other
|
|
$
|
535,860
|
|
|
$
|
455,767
|
|
|
$
|
2,200,539
|
|
|
$
|
2,065,891
|
|
Grant revenue
|
|
|
150,698
|
|
|
|
46,941
|
|
|
|
257,332
|
|
|
|
174,607
|
|
Total revenue
|
|
|
686,558
|
|
|
|
502,708
|
|
|
|
2,457,871
|
|
|
|
2,240,498
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Costs and expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of products and services
|
|
|
451,115
|
|
|
|
421,315
|
|
|
|
1,280,270
|
|
|
|
1,273,354
|
|
Research and development
|
|
|
297,298
|
|
|
|
244,032
|
|
|
|
1,208,160
|
|
|
|
988,597
|
|
Selling and marketing
|
|
|
286,872
|
|
|
|
394,538
|
|
|
|
1,009,568
|
|
|
|
1,209,334
|
|
General and administrative
|
|
|
1,166,003
|
|
|
|
761,207
|
|
|
|
3,436,956
|
|
|
|
3,416,261
|
|
Total operating costs and expenses
|
|
|
2,201,288
|
|
|
|
1,821,092
|
|
|
|
6,934,954
|
|
|
|
6,887,546
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating loss
|
|
|
(1,514,730
|
)
|
|
|
(1,318,384
|
)
|
|
|
(4,477,083
|
)
|
|
|
(4,647,048
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other (expense) income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense, net
|
|
|
(1,152,618
|
)
|
|
|
(1,623,470
|
)
|
|
|
(4,168,214
|
)
|
|
|
(6,055,420
|
)
|
Other expense
|
|
|
(211,726
|
)
|
|
|
(4,635
|
)
|
|
|
(15,135
|
)
|
|
|
(5,674
|
)
|
Impairment loss on investment
|
|
|
–
|
|
|
|
–
|
|
|
|
–
|
|
|
|
(6,069
|
)
|
Gain on extinguishment of embedded derivative liabilities
|
|
|
(74,678)
|
|
|
|
94,590
|
|
|
|
260,454
|
|
|
|
185,452
|
|
Incentive shares and warrants
|
|
|
(424,024)
|
|
|
|
–
|
|
|
|
(1,299,340
|
)
|
|
|
(186,802
|
|
Change in fair value of derivative liabilities
|
|
|
–
|
|
|
|
–
|
|
|
|
–
|
|
|
|
–
|
|
Total other (expense) income
|
|
|
(1,863,046
|
)
|
|
|
(1,533,515)
|
|
|
|
(5,222,235
|
)
|
|
|
(6,068,513
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income
|
|
|
(3,377,776
|
)
|
|
|
(2,851,899)
|
|
|
|
(9,699,318
|
)
|
|
|
(10,715,561
|
)
|
Deemed dividend on down round feature
|
|
|
–
|
|
|
|
–
|
|
|
|
(213,012)
|
|
|
|
–
|
|
Deemed dividend on beneficial conversion feature
|
|
|
(1,203,328)
|
|
|
|
–
|
|
|
|
(12,881,899)
|
|
|
|
–
|
|
Preferred stock dividends
|
|
|
(305,603)
|
|
|
|
–
|
|
|
|
(678,921)
|
|
|
|
–
|
|
Net (loss) attributable to common shareholders
|
|
$
|
(4,886,707)
|
|
|
$
|
(2,851,899)
|
|
|
$
|
(23,473,150)
|
|
|
$
|
(10,715,561)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) per common share – basic and diluted
|
|
$
|
(2.93
|
)
|
|
$
|
(2.37
|
)
|
|
$
|
(15.33
|
)
|
|
$
|
(9.62
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common stock shares outstanding used in the basic and diluted net (loss) income per share calculation
|
|
|
1,666,591
|
|
|
|
1,202,817
|
|
|
|
1,530,989
|
|
|
|
1,114,225
|
|
PRESSURE BIOSCIENCES, INC. AND SUBSIDIARY
CONSOLIDATED BALANCE SHEETS
|
|
December 31, 2018
|
|
|
December 31, 2017
|
|
ASSETS
|
|
|
|
|
|
|
|
|
CURRENT ASSETS
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
103,118
|
|
|
$
|
81,033
|
|
Accounts receivable, net of $0 reserve at December 31, 2018 and December 31, 2017
|
|
|
474,830
|
|
|
|
206,848
|
|
Inventories, net of $273,547 reserve at December 31, 2018 and $179,600 December 31, 2017
|
|
|
765,478
|
|
|
|
857,662
|
|
Prepaid income taxes
|
|
|
–
|
|
|
|
7,482
|
|
Prepaid expenses and other current assets
|
|
|
170,734
|
|
|
|
214,676
|
|
Total current assets
|
|
|
1,514,160
|
|
|
|
1,367,701
|
|
Investment in equity securities
|
|
|
16,643
|
|
|
|
19,825
|
|
Property and equipment, net
|
|
|
69,272
|
|
|
|
22,662
|
|
Right of use asset leases
|
|
|
136,385
|
|
|
|
–
|
|
Intangible assets, net
|
|
|
663,462
|
|
|
|
750,000
|
|
TOTAL ASSETS
|
|
$
|
2,399,922
|
|
|
$
|
2,160,188
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS’ DEFICIT
|
|
|
|
|
|
|
|
|
CURRENT LIABILITIES
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
658,856
|
|
|
$
|
589,263
|
|
Accrued employee compensation
|
|
|
456,932
|
|
|
|
368,700
|
|
Accrued professional fees and other
|
|
|
1,112,995
|
|
|
|
800,620
|
|
Other current liabilities
|
|
|
1,233,323
|
|
|
|
1,536,507
|
|
Deferred revenue
|
|
|
20,623
|
|
|
|
263,106
|
|
Revolving note payable, net of unamortized debt discounts of $0 and $637,030, respectively
|
|
|
–
|
|
|
|
3,500,000
|
|
Related party convertible debt, net of unamortized debt discounts of $0 and $31,372, respectively
|
|
|
–
|
|
|
|
259,762
|
|
Convertible debt, net of unamortized discounts of $156,180 and $401,856, respectively
|
|
|
4,000,805
|
|
|
|
8,028,014
|
|
|
|
|
|
|
|
|
|
|
Other debt, net of unamortized discounts of $9,118 and $48,194, respectively
|
|
|
852,315
|
|
|
|
1,379,863
|
|
Other related party debt
|
|
|
15,000
|
|
|
|
–
|
|
Total current liabilities
|
|
|
8,350,851
|
|
|
|
16,725,835
|
|
LONG TERM LIABILITIES
|
|
|
|
|
|
|
|
|
Right of use asset liability
|
|
|
136,385
|
|
|
|
–
|
|
Deferred revenue
|
|
|
37,757
|
|
|
|
57,149
|
|
TOTAL LIABILITIES
|
|
|
8,524,993
|
|
|
|
16,782,984
|
|
COMMITMENTS AND CONTINGENCIES (Note 7)
|
|
|
|
|
|
|
|
|
STOCKHOLDERS’ DEFICIT
|
|
|
|
|
|
|
|
|
Series D Convertible Preferred Stock, $.01 par value; 850 shares authorized; 300 shares issued and outstanding on December 31, 2018 and 2017, respectively (Liquidation value of $300,000)
|
|
|
3
|
|
|
|
3
|
|
Series G Convertible Preferred Stock, $.01 par value; 240,000 shares authorized; 80,570 shares issued and outstanding on December 31, 2018 and 2017, respectively
|
|
|
806
|
|
|
|
806
|
|
Series H Convertible Preferred Stock, $.01 par value; 10,000 shares authorized; 10,000 shares issued and outstanding on December 31, 2018 and 2017, respectively
|
|
|
100
|
|
|
|
100
|
|
Series H2 Convertible Preferred Stock, $.01 par value; 21 shares authorized; 21 shares issued and outstanding on December 31, 2018 and 2017, respectively
|
|
|
–
|
|
|
|
–
|
|
Series J Convertible Preferred Stock, $.01 par value; 6,250 shares authorized; 3,458 shares issued and outstanding on December 31, 2018 and 2017, respectively
|
|
|
35
|
|
|
|
35
|
|
Series K Convertible Preferred Stock, $.01 par value; 15,000 shares authorized; 6,880 shares issued and outstanding on December 31, 2018 and 2017, respectively
|
|
|
68
|
|
|
|
68
|
|
Series AA Convertible Preferred Stock, $.01 par value; 10,000 shares authorized; 6,499 and 0 shares issued and outstanding on December 31, 2018 and 2017, respectively
|
|
|
65
|
|
|
|
–
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, $.01 par value; 100,000,000 shares authorized; and 1,684,182 and 1,342,858 shares issued and outstanding on December 31, 2018 and 2017 respectively
|
|
|
16,842
|
|
|
|
13,429
|
|
Warrants to acquire common stock
|
|
|
19,807,247
|
|
|
|
9,878,513
|
|
Additional paid-in capital
|
|
|
39,777,301
|
|
|
|
30,833,549
|
|
Accumulated other comprehensive loss
|
|
|
|
|
|
|
–
|
|
Accumulated deficit
|
|
|
(65,727,538
|
)
|
|
|
(55,349,299
|
)
|
Total stockholders’ deficit
|
|
|
(6,125,071
|
)
|
|
|
(14,622,796
|
)
|
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT
|
|
$
|
2,399,922
|
|
|
$
|
2,160,188
|
|
VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) this morning announced receipt of local municipal approval for its wholly-owned subsidiary, Canna Farms Limited, for its phase 5 expansion that will add to its Hope, B.C. facility an incremental 2,500 kilograms of indoor capacity. According to the update, the expansion, originally slated to begin construction in 2020, is now, pending regulatory approval, expected to be completed in late 2019 or early 2020. The expansion, with expected capital costs of $3.5 million, consists of 10,000 square feet of cultivation space and is expected to bring VIVO’s total internal production capacity to 13,500 kilograms by early 2020. “Canna Farms is a cultivator and purveyor of premium quality, award winning, small-batch craft cannabis with widespread recognition and appeal as evidenced by its award for ‘Top Reviewed Licensed Producer of the Year’ at the 2018 Canadian Cannabis Awards,” VIVO CEO Barry Fishman said in the news release. “This expansion will further increase Canna Farms’ production capacity to help meet the significant market demand for premium B.C. dry bud. This project represents a strategic deployment of a minor portion of our strong cash position as the Company continues to invest to drive future growth.”
To view the full press release, visit: http://nnw.fm/Azch8
About VIVO Cannabis(TM)
VIVO Cannabis(TM), based in Napanee, Ontario, is recognized for trusted, high-quality products and services. It holds production and sales licenses from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical(TM), FIRESIDE(TM), Canna Farms(TM) and Lumina(TM). In August 2018, VIVO acquired Canna Farms, a premium cannabis company based in Hope, British Columbia. Canna Farms was B.C.’s first Licensed Producer and has several years of craft cultivation experience and expertise, as well as a significant patient base and positive cash flow. The Company is significantly expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, including Germany and Australia. VIVO also operates Harvest Medicine, a patient-centric and highly scalable network of specialty medical cannabis clinics as well as a free telemedicine app. VIVO has a healthy balance sheet and is well-positioned to accelerate its growth in Canada and internationally. For more information, visit the company’s website at www.VivoCannabis.com.
NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://nnw.fm/VVCIF
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
KELOWNA, BC / April 25, 2019 / Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, is pleased to announce new appointments to its Scientific Advisory Board, each of whom will contribute advice and recommendations and support related to the Company’s scientific research and product development. Lexaria is honored to have the opportunity of working with each of them.
Dr. Dwayne Godwin is Dean of the Graduate School and Professor in the Departments of Neurobiology and Anatomy and the Institute for Regenerative Medicine at Wake Forest University. He is a neuroscientist with extensive experience in studies of synaptic pharmacology of the brain and translational interests in the physiological basis and neuroimaging of brain injury, alcohol abuse, epilepsy and seizure, Alzheimer’s and PTSD. Dr. Godwin also has experience creating, developing and administering programs at the interface between science, technology, and business, and experience consulting with the pharmaceutical industry on preclinical drug development. He earned his PhD in Behavioural Neuroscience from the University of Alabama, and completed a Postdoctoral Fellowship at the State University of New York – Stony Brook.
Dr. Terry D. Blumenthal is Professor, Psychology and Neuroscience, at Wake Forest University, and is past president of the Society for Psychophysiological Research. His research interests include psychophysiology, research design and methodology, PTSD, information processing, schizophrenia, and developmental neuroscience. Dr. Blumenthal has over 115 publications and has delivered over 200 formal presentations at prestigious events held around the world. He earned both his PhD and MS degrees in Psychology from the University of Florida, and his BSc from the University of Alberta.
Dr. Matthew Fraser is Associate Professor and Director of Basic Science Research in the Department of Surgery, Division of Urology, at Duke University Medical Center. Dr. Fraser has extensive experience in urological and gastrointestinal neuroscience preclinical research, development of research models and methods, experimental design, and early clinical development in both academic and industry settings. He earned his PhD in Physiology/Neuroscience from the University of Pittsburgh School of Medicine.
Dr. Carla Lema Tome is an industry consultant an Adjunct Assistant Professor of Neurobiology and Anatomy at Wake Forest University School of Medicine. She is widely published on topics including but not limited to cellular and molecular neuroscience, inflammation, neurodegeneration, and cancer biology. She has extensive experience in global medical and commercial strategy consulting with emphasis on integrated clinical development, asset and portfolio strategy, launch planning payer research and payer value communications. Her work supporting bioscience projects with high market potential includes the development of forecast and valuation models, conducting strategic analyses of the competitive and market access environment, and developing integrated plans and innovative strategies to maximize asset value. Dr. Lema Tome earned her PhD in Neurobiology and Anatomy and her MBA from Wake Forest University. She also earned an MS in Biological Sciences, Marine Biology, from the Florida Institute of Technology.
“Lexaria Bioscience Corp. is very pleased to welcome these accomplished experts to our Advisory Board, who can provide critical scientific guidance to Lexaria’s ongoing and future R&D programs,” said Chris Bunka, Chief Executive Officer of Lexaria Bioscience Corp. “Lexaria is building towards becoming one of the world’s leaders in drug delivery technology and our most recent Advisors can assist in achieving that goal.”
About Lexaria
Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECH™ delivery technology. Lexaria’s technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules.
www.lexariabioscience.com
For regular updates, connect with Lexaria on Twitter https://twitter.com/lexariacorp and on Facebook https://www.facebook.com/lexariabioscience/
FOR FURTHER INFORMATION PLEASE CONTACT:
Lexaria Bioscience Corp.
Alex Blanchard, Communications Manager
(250)765-6424 Ext 202
FORWARD-LOOKING STATEMENTS
This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements, including but not limited to: that any additional stock warrants or stock options will be exercised. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition, the patent application and approval process and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that existing capital is sufficient for the Company’s needs or that it will be able to raise additional capital. There is no assurance that Lexaria will successfully complete any other contemplated or existing technology license agreements; or that results from any studies will be favorable or in any way support future business activities of any kind. Scientific R&D is often unpredictable and unanticipated results could emerge from any study and have a material impact. There is no assurance that any planned corporate activity, scientific study, R&D, business venture, or initiative will be pursued, or if pursued, will be successful. There is no assurance that any of Lexaria’s postulated uses, benefits, or advantages for the patented and patent-pending technology will in fact be realized in any manner or in any part. No statement herein has been evaluated by the Food and Drug Administration (FDA). TurboCBDTM, DehydraTECHTM technology and ViPovaTM products are not intended to diagnose, treat, cure or prevent any disease.
LOS ANGELES, April 25, 2019 — via NetworkWire — Los Angeles based Cannabis Strategic Ventures Inc. (OTC: NUGS) today announces a major addition to its corporate portfolio through the launch of a six-acre cannabis cultivation site expected to produce a minimum of 30,000 pounds of cannabis per harvest, with an anticipation of four to five harvests per year.
The site, which has been named NUGS Farm North, is located in Northern California. NUGS Farm North is primarily a cultivation operation but will also host manufacturing and distribution business units for Cannabis Strategic Ventures. In total, the site holds 24 cultivation, manufacturing and distribution licenses issued by the Bureau of Cannabis Control in the State of California. NUGS Farm North is expected to operate at maximum capacity by late summer of 2019.
“This is a significant event for Cannabis Strategic and its investors,” commented Simon Yu, CEO Cannabis Strategic Ventures. “NUGS Farm North has planted over 20,000 marijuana clones this week and will plant 10,000 more next week. Beyond the initiation of this first phase of NUGS farm North, we anticipate further expansion towards maximum capacity, which will increase top line revenue.”
Cannabis industry figures show that cannabis plants yield more than one pound of cannabis per harvest. In California, the wholesale price for cannabis opened 2018 at $1,455 per pound and closed the year at $1,196 per pound, averaging $1,197 per pound for the year, according to Cannabis Benchmarks.
The Company has retained a highly skilled team to operate NUGS Farm North consisting of experts with over a dozen years of full lifecycle cannabis operations, as well as research scientists with vast scientific, medical and laboratory backgrounds unique to cannabis operations.
“NUGS Farm North is in a prime location. We have assembled a great team to operate the site and to market and distribute its outputs. We have already begun cultivation and believe the marketplace is primed for the type of premium cannabis flower we are cultivating. We look forward to a successful operation at our flagship cultivation site,” added Yu.
About Cannabis Strategic Ventures
Cannabis Strategic Ventures is a Los Angeles-based firm that incubates, develops and partners with category leaders within the cannabis sector. The Firm’s NUGS brand experience provides operational and financial strategic partnerships and a range of essential services to emerging and existing cannabis consumer brands. The company recently completed a name and symbol change from Cascade Energy, Inc. Cannabis Strategic Ventures is publicly traded on the U.S. Over the Counter Market with the stock symbol NUGS. For more information, visit www.CannabisStrategic.com
FORWARD-LOOKING STATEMENTS: This release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management’s current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “would,” “could,” “will” and other words of similar meaning in connection with a discussion of future operating or financial performance.
Examples of forward-looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance.
Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company’s actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others such as, but not limited to economic conditions, changes in the laws or regulations, demand for products and services of the company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. Any forward-looking information provided in this release should be considered with these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.
Contact:
Arlene Guzman
1-310-359-6860 Office
IR@CannabisStrategic.com
www.CannabisStrategic.com
Corporate Communications:
NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com
Youngevity International (NASDAQ: YGYI), a leading omni-direct lifestyle company, recently announced that its Khrysos Global subsidiary secured a contract to produce 99% pure cannabidiol oil from hemp with no tetrahydrocannabinol (THC). An article discussing the company reads, “The one-year supply and processing agreement is expected to begin with shipments this month and continue in equal amounts through March 2020, amounting to what Khrysos President Dwayne Dundore described as 50 percent of the company’s production capacity utilizing its supercritical CO2 technology (http://nnw.fm/CktQ0). Contracts for the remainder of the company’s production capacity are expected to be executed during ‘the next few months,’ he added. . . . ‘We are excited to reach the revenue stage for the end-to-end processing component of our business model,’ Dundore stated in the news release. ‘Due to customer demand, we are implementing our plan of increasing our end-to-end processing capabilities by 10 times in Q3 of this year, providing estimated annual revenue potential in excess of $220 million at current market prices.’”
To view the full article, visit: http://nnw.fm/dfn0V
About Youngevity International Inc.
Youngevity International Inc. is a multichannel lifestyle company operating in three distinct business segments — a commercial coffee enterprise, a commercial hemp enterprise and an omni-direct selling platform. The company features an international selling network and has assembled a virtual main street of products and services under one corporate entity. YGYI offers products from the six top-selling retail categories, including health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry and innovative services. For more information, visit the company’s website at www.YGYI.com.
NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://nnw.fm/YGYI
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
Kelowna, British Columbia / April 24, 2019 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, announces that it has entered a definitive 5-year agreement, via its subsidiary Lexaria CanPharm ULC, to provide Lexaria’s patented DehydraTECHTM technology to a private California-based cannabis company for its utilization in certain cannabis-based beverages to be produced and sold in the states of California and Nevada.
Financial terms of the agreement are not being disclosed. The DehydraTECH-enabled beverages are protected under Lexaria’s many existing US-granted patents and may include any combination of ready-to-drink beverages such as non-alcoholic beers, wines and spirits; cold or hot coffee or teas, sports drinks and much more.
Lexaria has developed methods of combining nano-emulsion technology with its proprietary DehydraTECH processes to create beverages with market-leading aesthetic and performance characteristics. Lexaria is currently experiencing unprecedented demand in several North American markets for use of its technology for beverage applications.
About Lexaria
Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECH(TM) delivery technology. Lexaria’s technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs),nicotine and other molecules.
www.lexariabioscience.com
FOR FURTHER INFORMATION PLEASE CONTACT:
Lexaria Bioscience Corp.
Alex Blanchard, Communications Manager
(250)765-6424 Ext 202
Or
NetworkNewsWire (NNW)
www.NetworkNewsWire.com
FORWARD-LOOKING STATEMENTS
This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements, including but not limited to: that any additional stock warrants or stock options will be exercised. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition, the patent application and approval process and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that existing capital is sufficient for the Company’s needs or that it will be able to raise additional capital. There is no assurance that Lexaria will successfully complete any other contemplated or existing technology license agreements; or that results from any studies will be favorable or in any way support future business activities of any kind. Scientific R&D is often unpredictable and unanticipated results could emerge from any study and have a material impact. There is no assurance that any planned corporate activity, scientific study, R&D, business venture, or initiative will be pursued, or if pursued, will be successful. There is no assurance that any of Lexaria’s postulated uses, benefits, or advantages for the patented and patent-pending technology will in fact be realized in any manner or in any part. No statement herein has been evaluated by the Food and Drug Administration (FDA). TurboCBDTM, DehydraTECHTM technology and ViPovaTM products are not intended to diagnose, treat, cure or prevent any disease.
Conference Call Scheduled for Thursday, April 25th at 4:30pm ET
SOUTH EASTON, MA / April 24, 2019 / Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”) today announced that the Company will host a teleconference to discuss its Fourth Quarter and Fiscal Year 2018 financial results and to provide a business update. Anyone interested may listen to the teleconference either live (by telephone) or through a replay (by telephone or via a link on the Company’s website approximately one day after the teleconference).
The teleconference will include a Company presentation followed by a question & answer period.
Date: Thursday, April 25, 2019 Time: 4:30 PM Eastern Time (ET)
To attend this teleconference, live by telephone:
Dial-in: (844) 602-0380 (North America); (862) 298-0970 (International)
Verbal Passcode (for the operator): PBI Fourth Quarter and FY 2018 Financial Call & Business Update
For those unable to participate in the live teleconference, a replay will be available beginning Friday, April 26, 2019. The replay will be accessible via telephone and the Company’s website for 30 days.
Replay Number: (877) 481-4010 (North America); (919) 882-2331 (Int’l); Replay Passcode: 47337
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired, patented technology from BaroFold, Inc. (the “BaroFold” technology) to allow entry into the biologics contract research services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.
For more information about PBI and this press release, please click on the following link:
http://www.pressurebiosciences.com
Please visit us on Facebook, LinkedIn, and Twitter.
Investor Contacts:
Richard T. Schumacher, President & CEO (T) 508-230-1828
Bradford A. Young, Ph.D., MBA, SVP & CCO (F) 508-230-1829
Net Element (NASDAQ: NETE), a global technology and value-added solutions group, recently reported substantial financial growth in 2018. A recent article discussing the company reads, “The company’s revenue over the year went up to $65.8 million, marking an increase of 10 percent on an annual basis. Growth through the company’s North American transaction solutions segment was the primary driver for the strong results, as the company’s management announced in an earnings conference call on April 2, 2019 (http://nnw.fm/sF47f). . . . The North American transaction solutions segment experienced annual growth of 16 percent in 2018. The United States accounted for 90 percent of the overall revenue, while international revenue contributed 10 percent.”
To view the full article, visit: http://nnw.fm/6ScYq
About Net Element Inc.
Net Element (NASDAQ: NETE) operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the United States and selected emerging markets. In the U.S., the company aims to grow transactional revenue by innovating SME productivity services using blockchain technology solutions and Aptito, the company’s cloud-based, restaurant and retail point-of-sale solution. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest-growing companies in North America on Deloitte’s 2017 Technology Fast 500. In 2017, Net Element was recognized by South Florida Business Journal as one of 2016’s fastest-growing technology companies. Further information is available at www.NetElement.com.
NOTE TO INVESTORS: The latest news and updates relating to NETE are available in the company’s newsroom at http://nnw.fm/NETE
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
- TransCanna Holdings’ purchase of a 5.5-acre site in Northern California with a 196,000-square-foot facility onsite is expected to set the stage for the company’s self-contained ecosystem to create or acquire 15 premium brands by controlling all aspects of production, distribution and sales
- Cannabis sales in California are expected to reach $5.1 billion this year and climb to $7.7 billion by 2022
- TransCanna’s site purchase advances plans for an additional 600,000-square-foot facility for biomass growth
- A successful, oversubscribed private placement raised gross proceeds of C$16 million to help fund plans for the site
Cannabis branding and distribution company TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) has finalized the acquisition of “arguably the largest vertically integrated cannabis centric” multi‐purpose facility in California, setting the stage for edification of a self-contained cannabis hub operation that includes integrated divisions for transportation and distribution, cultivation and nursery, lab extraction, manufacturing and packaging.
The three-story, 196,000-square-foot facility is part of a larger 5.5-acre property purchase that the company envisions as green space, where up to 600,000 square feet of new …
Read more »
NOTE TO INVESTORS: The latest news and updates relating to TCAN are available in the company’s newsroom at http://nnw.fm/TCAN
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
Vancouver, British Columbia–(April 23, 2019) – TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8) (“TransCanna” or the “Company”) announces that the acquisition of GoodFellas will result in acquiring an additional existing brand called Daily Cannabis Goods (“Daily”). The Daily brand consists of three quality half gram pre-rolls which are attractively packaged and priced.
“The Daily brand is a perfect fit for TransCanna,” Stated Jim Pakulis, CEO of TransCanna. “The start-up costs were nominal, it has SKU velocity now that it’s selling in over thirty dispensaries, and it’s constantly beating the competition due to consumer demand.”
“The Daily brand has seen a steady consistent increase in sales since it commenced in August 2018. The first month shipments of units exceeded 2,100 and by December the number of units shipped for the month exceed 10,000. We anticipate closing the acquisition of GoodFellas by May 20th, and then we’ll budget accordingly in order to work on increasing units sold.”
Subsequent to the acquisition, TransCanna anticipates expanding the Daily line to include three additional SKU’s.
For further information, please visit the Company’s website at www.transcanna.com.
About TransCanna Holdings Inc.
TransCanna Holdings Inc. is a Canadian-based company focused on providing integrated branding, transportation and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace.
For further information, please visit the Company’s website at www.transcanna.com or email the Company at info@transcanna.com.
Media Contact
TransCanna@talkshopmedia.com
604-738-2220
On behalf of the Board of Directors
James Pakulis
Chief Executive Officer
Telephone: (604) 609-6199
The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Company believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
In a press release earlier today, The Green Organic Dutchman (TSX:TGOD) (OTCQX:TGODF) announced that it has received its oil sales license from Health Canada. The news has spurred on TGOD stock, which, as a result, is up roughly 7% and trading at $4.18 CAD on the TSX.
TGOD Stock: Oil Sales License
The news comes a short time after the company received its oils production license earlier this month.
Upon that news, TGOD installed a “state-of-the-art supercritical CO2 extraction system, capable of processing ultra-pure, environmentally friendly, organic cannabis oils.”
This focus on high-quality certified-organic cannabis is exactly what TGOD is famed for. Its aim to create ultra-premium cannabis products is possible because of the company’s extraction process. This is a unique protocol that results in a cannabis oil “as close to the original plant composition” as possible.
Now, with the sales license in hand, TGOD will embark on the global sale of this high-quality cannabis oil, much to the excitement of TGOD stock investors.
In the press release, TGOD CEO Brian Athaide said the following:
“We are pleased to offer TGOD’s medical patients access to new premium certified organic cannabis oils […] In addition, this step will assist TGOD in transforming our premium quality organic raw material into a variety of higher-margin cannabis products which is core to our business plan, providing us with the opportunity to bring to market innovative and novel products, including beverages and edibles, once regulations permit. Cannabis 2.0 is rapidly approaching, and we will be ready.”
TGOD Stock: Grower’s Circle
In March, The Green Organic Dutchman announced that the sale of its cannabis flower had started. A select group of medical patients called the Growers’ Circle, were given early access to the company’s first-certified organic flower. This initial rollout was a limited offering used to help TGOD perfect distribution and gauge response ahead of the company’s full-scale rollout, which will now include cannabis oils.
Initial feedback from the Grower’s Circle has, according to the company, been extremely positive.
Now, TGOD’s Unite Organic Cannabis Oil will begin shipping later this month.
Palm Beach FL – April 23, 2019 – Canada was the first North American country to legalize cannabis and that gave it an advantage, but it is the U.S. that is projected to have the larger number of consumers in 2019. U.S. companies will need the expertise of the Canadian growers and Canadian growers will need to work with U.S. companies to enter this larger market. Mergers and marriages should abound in 2019. Bloomberg, has said that recently, most U.S.-focused cannabis companies saw higher gross margins than their Canadian counterparts, and as a result, many of Canadian companies are beginning to establish operations in the U.S. Conversely, even with the U.S. having vast growth opportunities, U.S. cannabis companies are still expanding their operations in Canada. According to Arcview Market Research and BDS Analytics, Canada reported legal cannabis sales in the range of USD $755 Million to USD $1.6 Billion. So in the near future, the U.S. and Canada combined, are projected to be the biggest market drivers for the global cannabis industry. Active companies in the cannabis industry includes: CROP INFRASTRUCTURE CORP. (CSE:CROP) (OTC:CRXPF), CV Sciences, Inc. (OTC: CVSI), Green Growth Brands Inc. (CSE: GGB) (OTC: GGBXF), Newstrike Brands Ltd. (TSX-V: HIP) (OTC: NWKRF), The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF).
A recent Forbes article had the following headline: “2019 Explosion Of Cannabis Mergers And Acquisitions Predicted”. The article continued: “Most of the businesses growing, processing and selling cannabis across the United States are small independently-held entities. That may change in 2019 which looks like a big year for industry mergers, acquisitions and expansion. The cannabis industry still has a mom and pop feel but that could change rapidly. A few have made that leap and are establishing footholds in states around the country. In 2018, some of the multi-state operators acquired additional licensed operators in new locations. By the end of the year, “We were seeing larger companies merge with one another,” said (an industry insider). As the industry continues to grow and mature, he expects to see more of this consolidation in 2019.”
CROP INFRASTRUCTURE CORP. (CSE:CROP) (OTCPK:CRXPF) (Frankfurt: 2FR) BREAKING NEWS: CROP announced today that it has completed the construction of its 57,600 square foot nursery in Nye County, Nevada. It has been equipped with trays and LED lighting specially designed to enhance the growth of plant starts for the 2019 CBD farms licenced on the company’s various properties in the state. This was a key project in order to maximize yield, reduce farming risk and costs for the 2019 planting season.
CROP continues to gauge interest and review potential off take relationships for the 2019 season for its CBD products. The global medical cannabis market value is expected to reach a value of US$ 45.4 Billion by 2024, with a CAGR of 22.9% during 2019-2024, according to IMARC research. The firm’s estimate for last year was that it would to reach US$ 13.4 Billion.
CROP CEO, Michael Yorke, stated: “The CROP family of companies and subsidiaries continues to build strategic infrastructure in key states where we are present. These are one time builds that will streamline harvests, reduce risks and costs as well as maximize yields for many years to come.
“We are very proud of our team members for putting in the extra hours to ensure the season ahead is as successful and profitable as can be. We are encouraged by the number of interested parties in the products we are producing and will look to secure long term reliable relationships to the benefit of stakeholders and the company’s farming, marketing and construction divisions.” Read this full announcement and more news for CROP Infrastructure at: https://www.financialnewsmedia.com/news-crop/
Additional cannabis industry related developments from around the markets:
CV Sciences, Inc. (OTCQB: CVSI) a preeminent supplier and manufacturer of hemp CBD products, recently announced further expansion of its industry-dominating brand, PlusCBD Oil™. As of March 31, 2019, PlusCBD Oil™ branded products are available in 3,308 retail stores, up 48% from 2,238 retail stores as of December 31, 2018.
The expansion includes broadening distribution of its best-selling topical, PlusCBD Oil™ Extra Strength Balm, into the Food, Drug and Mass (FDM) channel, including programs with leading national retailers.
Green Growth Brands Inc. (CSE: GGB.CN) (OTCQB: GGBXF) a cannabis and CBD retailer specializing in creating remarkable consumer experiences, recently announced the launch of CAMP™, a proprietary cannabis brand.
CAMP™ is a brand born from the idea of connecting with nature, connecting with others and connecting with yourself. A strategic component of GGB’s owned and operated portfolio of brands, CAMP™ will be a destination for the cannabis community; a place to find premium products that support and enhance an active lifestyle. Beginning with proprietary TCH and CBD products, GGB expects to also launch the first CAMP dispensary in this year.
Newstrike Brands Ltd. (TSX-V: HIP.V) (OTCPK: NWKRF) recently announced that it is making a US$5 million investment in Green Tank Technologies (“Green Tank”), one of North America’s premiere manufacturers of cannabis vape hardware and technology. The investment by Newstrike strengthens the existing partnership between Newstrike’s wholly-owned subsidiary, Up Cannabis, and Green Tank, as both companies prepare for the legalization of cannabis oil vaping.
“In anticipation of revised cannabis regulations coming into force in late 2019, we are gearing up for the commercial launch of our full line of cannabis vape products. Our strategic investment in Green Tank puts us in a strong position to become a preferred supplier of end-to-end vape solutions to the adult use recreational market,” said Mark E. Burton , Chief Strategy Officer, Newstrike Brands.
The Green Organic Dutchman Holdings Ltd. (TSX: TGOD.TO) (OTCQX: TGODF) recently announced it has received its oil sales license from Health Canada pursuant to the Cannabis Act for its Hamilton, Ontario facility.
The Company received its oils production license in April of 2018 and subsequently installed a state-of-the-art supercritical CO2 extraction system, capable of processing ultra-pure, environmentally friendly, organic cannabis oils. The process is free of toxic solvents and does not require any winterization protocol. The result of this specialized extraction process is a precisely concentrated, aromatic golden-brown oil that is as close to the original plant composition as can be achieved. TGOD’s premium cannabis products, including its cannabis oils, are certified organic by ProCert and its innovative growing process is certified organic by both ProCert and Ecocert, producing a clean, high-quality end product.
DISCLAIMER: FN Media Group LLC (FNM), which owns and operates FinancialNewsMedia.com and MarketNewsUpdates.com (FNM) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with any company mentioned herein. FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNM is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNM has been compensated forty nine hundred dollars for news coverage of the current press release issued above by CROP Infrastructure Corp. by a non affiliated third party. FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.
Cannabis has become the New Gold Rush of 2019.Legalization in North America. Growing acceptance in the global community, as well as sizable interest from corporate America is quickly fueling a sizable boom.
Just took at the booming cannabis beauty market, for example.
“There is a great deal of room for innovation in his sector, and topicals and beauty products are expected to explode with legalization and the entry of major consumer packaged goods companies,” notes market research firm, The Brightfield Group.
In fact, thanks to cannabis, profit margins for concentrates and infused products in the sector are estimated at around 32% – significantly higher than those typically realized by alcohol, soft drinks, and cigarettes, according to the Marijuana Business Factbook.
Some of the top companies benefiting from the news are The Yield Growth Corporation (CSE:BOSS)(OTCQB:BOSQF), Estee Lauder Companies Inc. (NYSE:EL), Khiron Life Sciences Corp. (TSXV:KHRN)(OTC:KHRNF), Sephora USA Inc., a subsidiary of LVMH Moet Hennessey Louis Vuitton (OTC:LVMUY), and Canopy Rivers Inc. (TSXV:RIV)(OTC:CNPOF).
The Yield Growth Corporation’s (BOSS)(BOSQF) was successful in its application to get an International Nomenclature Cosmetic Ingredient (INCI) name assigned to the hemp root oil it manufactures with its patent pending extraction technology and uses in 150 of its cannabis and hemp-based beauty and wellness formulas.
The Personal Care Products Council (PCPC) assigned the INCI name “Cannabis Sativa Root Extract (and) Caprylic/Capric Triglyceride (and) Ricinus Communis (Castor) Seed Oil” to the hemp root oil manufactured by The Yield Growth Corp.
“We serve mainstream luxury consumers who seek sophisticated wellness products and we are now engaging with luxury retail stores about launching our products internationally,” says Yield Growth CEO Penny Green. “Having an assigned INCI name for our key ingredient Hemp Root Oil will make it easier for us to create international labels for our products as we roll out international expansion.”
For More Information on The Yield Growth Corporation, Click Here.
Estee Lauder (EL) is one of the biggest cosmetics companies to make the move into cannabis cosmetics, as well. In fact, its Origins company launched a face mask called, “Hello, Calm,” which is infused with cannabis sativa seed oil from hemp.
According to an Origins press release, the facial mask is infused with cannabis sativa seed oil, aka hempseed oil, rather than CBD oil. Hempseed, like CBD, is non-intoxicating. Origins claims that Hello, Calm “helps to soothe the mood and de-stress the senses.”
For More Information on Estee Lauder Companies Inc., Click Here.
Khiron Life Sciences Corporation (KHRN)(KHRNF) just signed multi-channel distribution agreement for its Kuida cosmeceutical brand with Fedco and Linio, two of the most prominent consumer distribution channels for wellness and beauty products in Colombia.
In combination with the initial product launch through Farmatodo and Farmalisto, it is anticipated that the Kuida brand will now be made available in up to 78 retail locations and through the country’s leading online portal for beauty products. Initially focused on distribution in Colombia, these agreements create potential for the Company to further expand distribution across other Latin America jurisdictions.
In addition, analysts at Canaccord Genuity note, “the company has a significant number of potential catalysts that should keep share price momentum going. Commercial sales of medical CBD products are expected in the early part of Q2, while a generous commercial THC quote toward mid-year could further validate Khiron’s distribution strategy. The passing of Mexican medical and recreational cannabis laws (likely in Q2) are also significant potential catalysts.”
For More Information on Khiron Life Sciences Corporation, Click Here.
Sephora USA Inc., a subsidiary of LVMH Moet Hennessey Louis Vuitton, introduced “High Beauty,” its first cannabis-infused cosmetic line. The line launched two new products called, High Expectations (a cannabis facial oil) and High Five (a cannabis facial moisturizer).
For More Information on Sephora USA Inc., Click Here.
Canopy Rivers Inc. (RIV)(CNPOF) is an investment and operating platform that pursues investment opportunities in the emerging global cannabis sector. It identifies strategic counterparties from around the world seeking financial and/or operating support including licensed producers, pharmaceutical formulators, brand developers and distributors, as well as consumer products and brands.
Canopy Rivers also just invested in High Beauty, the company behind cannabis beauty brand, High. The High brand includes skin products containing sativa seed oil in combination with plant oils and antioxidants.
“We have been actively pursuing opportunities in the health and beauty industry, guided by a growing consumer trend of brand new, innovative and functional beauty products. Enter high,” said Narbe Alexandrian, President of Canopy Rivers. “High has already captured mindshare and awareness of consumers – it has all the makings to continue to be a prominent brand in the cannabis-infused beauty market.”
For More Information on Canopy Rivers Inc., Click Here.
MarijuanaStox.com is a leading web destination for all cannabis related companies. Investors can also find current marijuana-related quality financial, medical, legal and social news.
MarijuanaStox.com is a media agency in North America dedicated to the cannabis industry, helping companies that operate in the space to attract quality investors, working capital and real publicity. Since 2005, we have had public companies in the US and Canada have rely on us to grow and succeed.
Legal Disclaimer
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media which has a partnership with www.MarijuanaStox.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.
For making specific investment decisions, readers should seek their own advice. Winning Media, which has a partnership with www.MarijuanaStox.com, is only compensated for its services in the form of cash-based compensation. Pursuant to an agreement between Winning Media (partners of MarijuanaStox.com) and The Yield Growth Corp, Winning Media has been paid four thousand dollars for advertising and marketing services for The Yield Growth Corp. We own ZERO shares of The Yield Growth Corp. Please click here for full disclaimer.
Contact Information:
2818047972
ty@marijuanastox.com
TORONTO, April 22, 2019 – The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX:TGOD) (US:TGODF) is pleased to announce it has received its oil sales licence from Health Canada pursuant to the Cannabis Act for its Hamilton, Ontario facility.
The Company received its oils production licence in April of 2018 and subsequently installed a state-of-the-art supercritical CO2 extraction system, capable of processing ultra-pure, environmentally friendly, organic cannabis oils. The process is free of toxic solvents and does not require any winterization protocol. The result of this specialized extraction process is a precisely concentrated, aromatic golden-brown oil that is as close to the original plant composition as can be achieved. TGOD’s premium cannabis products, including its cannabis oils, are certified organic by ProCert and its innovative growing process is certified organic by both ProCert and Ecocert, producing a clean, high-quality end product.
TGOD’s oil extraction facility was built to GMP (Good Manufacturing Practices) specifications, and work is currently underway for European Union GMP (“EU-GMP”) certification, which will allow the Company to expand distribution of its certified organic cannabis oils beyond Canada to global markets.
“We are pleased to offer TGOD’s medical patients access to new premium certified organic cannabis oils,” said Brian Athaide, TGOD CEO. “In addition, this step will assist TGOD in transforming our premium quality organic raw material into a variety of higher-margin cannabis products which is core to our business plan, providing us with the opportunity to bring to market innovative and novel products, including beverages and edibles, once regulations permit. Cannabis 2.0 is rapidly approaching, and we will be ready,” continued Athaide.
TGOD’s oils will be as close to the original plant as possible, including terpene profiles to realize entourage effects. The process is easily customizable to create full-spectrum strain-specific oils, as well as oils of varying cannabinoid and terpene concentrations.
“Oil is predominantly a medical product, and patients want clean, organic efficacy with safe and easy delivery,” said Dr. Rav Kumar, Chief Science Officer of TGOD. “Through our certified organic product and process we know we are providing patients the best possible experience.”
In March, the first group of patients, the Growers’ Circle, received access to purchase TGOD’s first certified organic cannabis strain through the website and the feedback has been extremely positive from all across the country. TGOD’s Unite Organic Cannabis Oil, derived from a high-potency THC-dominant strain, will begin shipping later this month.
To sign up for the Unite Organic waitlist, please visit TGOD’s patient center at TGOD.ca or call 905-304-4201.
On Behalf of the Board of Directors,
The Green Organic Dutchman Holdings Ltd.
About The Green Organic Dutchman Holdings Ltd.
The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) is a publicly traded, premium global organic cannabis company, with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned capacity of 219,000 kgs and is building 1,643,600 sq. ft. of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark.
TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively.
For more information on The Green Organic Dutchman Holdings Ltd., please visit www.tgod.ca.
Forward-Looking Information Cautionary Statement
This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward looking statements in this release includes, but is not limited to, statements about future research, development and innovation by the Company, statements about EU-GMP certification, statements about production timing, efficiencies, capacities and ramp-up, statements about future production, revenue, export capabilities and cashflows, statements about the offering or efficacy of any particular products by the Company in any jurisdiction and statements regarding the future performance of the Company. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accept responsibility for the adequacy or accuracy of this release.
Clinical-stage, gene-therapy company Genprex (NASDAQ: GNPX) is focused on the development of potentially life-changing technologies for cancer patients. A recent article discussing GNPX reads, “Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer. . . . Genprex’s initial product candidate is Oncoprex, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.”
To view the full article, visit: http://nnw.fm/31Ewc
About Genprex Inc.
Genprex Inc. is a clinical-stage, gene-therapy company developing potentially life-changing technologies for cancer patients, based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex(TM) immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale, hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities. Oncoprex has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis, or programmed cell death, in cancer cells and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance. For more information, visit the company’s website at www.Genprex.com.
NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://nnw.fm/GNPX
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
- Genprex’s collaborators at MD Anderson reported positive preclinical data for the combination of the TUSC2 gene with an anti-PD1 antibody for the treatment of non-small cell lung cancer
- The TUSC2 gene, a tumor suppressor gene, is the active agent in Genprex’s Oncoprex immunogene therapy, the company’s lead drug candidate for the treatment of lung cancer
- In combination with pembrolizumab, the TUSC2 gene significantly slowed tumor growth in mice with human immune cells
- Lung cancer ranks among the malignancies that are expected to increase the most in the coming years, especially among women; immunotherapy solutions may provide an effective option for the treatment of such cancers
Genprex Inc. (NASDAQ: GNPX), a clinical stage gene therapy company, reported in a press release that its University of Texas MD Anderson Cancer Center collaborators have recorded positive preclinical data in a lung cancer treatment study (http://nnw.fm/8E4bC). The results of the study, which analyzed the combination of the TUSC2 gene and anti-PD1 antibody pembrolizumab, were presented in a poster at the 2019 American Association of Cancer Research Meeting. TUCS2 is a tumor suppressor gene and the active agent in Genprex’s Oncoprex immunogene therapy.
The poster data showed that TUCS2 in combination with checkpoint blockade was more effective than checkpoint blockade alone in increasing the survival of mice with…
Read more »
NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://nnw.fm/GNPX
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, recently entered into a multiyear extraction services contract with Valens GroWorks Corp. (CSE: VGW) (OTCQB: VGWCF). An article discussing the deal reads, “The agreement with Valens, a licensed provider of cannabis products and services specializing in various proprietary extraction, distillation, cannabinoid isolation and purification technologies, will accelerate TGOD’s Canadian hemp strategy and allow for early market entry of TGOD’s organic hemp-derived CBD product lines within the coming months. Under the terms of the initial two-year agreement, Valens will process, extract and purify TGOD’s cannabis and hemp biomass under conditions specified by TGOD, as demanded by final product manufacturing and formulation requirements. . . . ‘We are excited to work with TGOD, Canada’s premier certified organic producer,’ Tyler Robson, CEO of Valens, added in the release. ‘Organic resonates with consumers, and Valens looks forward to helping accelerate TGOD’s time to market with the launch of its hemp-derived CBD product line in the coming months.’”
To view the full article, visit: http://nnw.fm/GD5o4
About the Green Organic Dutchman Holdings Ltd.
The Green Organic Dutchman Holdings is a publicly traded, premium global organic cannabis company with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. The company grows high-quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned global capacity of 219,000 kgs. and is building 1,643,600 square feet of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark. For more information, visit the company’s website at www.TGOD.ca.
NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://nnw.fm/TGODF
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) this morning announced the launch of CAMP(TM), its proprietary cannabis brand born from the idea of connecting with nature, others and yourself. According to the update, the brand’s debut product, Happy Camper, is available now at The Source dispensaries in Las Vegas and Henderson and marks Nevada’s first of its kind cartridge featuring 100 percent solventless rosin. Through CAMP(TM)’s proprietary extraction method, only pressure and heat is used to create the most natural, premium tasting rosin made from Anslinger and Grapefruit Durban terpenes. “At the heart of what we do is creating brands, products, and experiences that people love,” Green Growth Brands CEO Peter Horvath stated in the news release. “One of our differentiators is the ability to develop and launch new brands that will grow into substantial businesses. We are so proud to officially launch CAMP, and are excited to bring more CAMP products to our loyal customers in Nevada and beyond.”
To view the full press release, visit: http://nnw.fm/V5ryo
About Green Growth Brands
Green Growth Brands creates remarkable experiences in cannabis and CBD, led by CEO Peter Horvath and a leadership team of consumer-focused retail experts. The company’s brands include CAMP, Seventh Sense Botanical Therapy, The+Source, Green Lily and Meri + Jayne, with a licensing agreement with the Greg Norman Brand. Already boasting the strongest sales per square feet in the cannabis industry, GGB is expanding its presence in Nevada, Massachusetts and Arizona with CBD presence at ShopSeventhSense.com, in malls across the country and at DSW shoe stores—and that’s just the beginning. For more information, visit the company’s website at www.GreenGrowthBrands.com.
NOTE TO INVESTORS: The latest news and updates relating to GGBXF are available in the company’s newsroom at http://nnw.fm/GGBXF
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
Vancouver, British Columbia–(April 18, 2019) – TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8) (“TransCanna” or the “Company”) announces that it has executed a sub-lease agreement for 10,000 square feet of a multipurpose facility located in Adelanto, CA. The terms of the sub-lease agreement is four years at US$2.00 per square foot per month. The facility is of superior quality and has existing armed security personnel at all times at the complex.
“As we’ve represented since the commencement of TransCanna, it’s crucial to have a main facility, which we now have with the acquisition of the 196,000 square foot vertically integrated facility in Modesto, and up to five satellite facilities located strategically throughout the state,” stated Jim Pakulis, CEO of TransCanna. “This is in preparation for TransCanna to provide our clients with up to fifteen reliable, consistent branded products in a timely manner. In order to do that to scale, we needed to have a significant size nursery, grow, manufacturing, bottling, baking, extracting, and transportation and distribution facility and satellite offices, which we now have. Separately but related, we negotiated lease terms that are approximately thirty percent below market rates, with the added benefit of a completely fenced complex and armed security guards present at all times.”
The Company has terminated a previously signed LOI for 15,000 square feet for $2.25 per square foot per month. The landlord of that lease has yet to complete the facility as originally expected.
The Company has extended its marketing contract with Rok Marketing (a/k/a Rok Management) on existing terms with the exception of increasing the number of shares issuable per month to 30,000. All securities issuable will be subject to a four month hold period pursuant to the policies of the CSE.
For further information, please visit the Company’s website at www.transcanna.com.
About TransCanna Holdings Inc.
TransCanna Holdings Inc. is a Canadian-based company focused on providing integrated branding, transportation and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace.
For further information, please visit the Company’s website at www.transcanna.com or email the Company at info@transcanna.com.
Media Contact
TransCanna@talkshopmedia.com
604-738-2220
On behalf of the Board of Directors
James Pakulis
Chief Executive Officer
Telephone: (604) 609-6199
The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Forward-looking statements in this news release include, but are not limited to: the anticipated timing of the closing of the facility acquisition and the use of proceeds from the financing. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Company believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
LOS ANGELES, April 17, 2019 — via NetworkWire — Los Angeles-based Cannabis Strategic Ventures, Inc. (OTC: NUGS) congratulates portfolio company The Asher House Wellness on its continuing drive to expand the Asher House mission. Most notably, company co-founders Lee Asher and Luke Barton appeared on ABC’s “The Ellen DeGeneres Show” this week to discuss their deep commitment to move dogs out of shelters and into loving homes on a national and international level. The Asher House team, which depends on sales of hemp-based “Asher House Wellness Thrive Oil” to fund outreach efforts, is also introducing new phytocannabinoid (CBD) products as part of the Asher House Wellness product offerings.
“We are so grateful for the continued growth of The Asher House. The more people know about the Asher House, the more dogs we will be able to rescue,” said Lee Asher. “In addition, the more the community knows about and supports the Asher House Wellness and their industry-leading products that help dogs live well and thrive, the longer we will be able to continue our mission.”
In 2017, the Asher House founders embarked on a cross-country mission to get dogs out of shelters and into loving homes. Since then the brand’s co-founders have been traveling from state to state and Canada in an RV with six rescue dogs, working closely with local animal shelters or humane societies to set up dog adoption events. To date, the Asher House has successfully enabled the adoption of over 200 dogs.
“Cannabis Strategic Ventures is proud to support The Asher House mission and their commitment to help get dogs adopted throughout the United States and Canada,” said Simon Yu, CEO, Cannabis Strategic Ventures. “It is rare to find a company that is walking the talk and creating industry leading products while also dedicating personal resources to help their mission.”
The Ellen Show episode featuring The Asher House team and their adoption efforts was first aired April 15, 2019, and can be seen on EllenTube in a clip titled, “Ellen Meets Inspiring Dog Adoption Duo.” The Ellen Show currently has 31 million followers on YouTube to complement its national reach.
The Asher House Wellness team plans to launch several new dog products in 2019 that includes “Lillie’s Love Biscuits.”
“We are excited for future Asher House Wellness and their commitment to creating products that encourage the happiness, health, and well-being of dogs and their humans worldwide,” added Yu.
Cannabis Strategic Ventures acquired a controlling interest in The Asher House Wellness, a brand producing pet goods created with full-spectrum, whole-plant hemp, free of THC and pesticides, in 2018 (http://nnw.fm/3hKpk).
About Cannabis Strategic Ventures
Cannabis Strategic Ventures is a Los Angeles-based firm that incubates, develops and partners with category leaders within the cannabis sector. The Firm’s NUGS brand experience provides operational and financial strategic partnerships and a range of essential services to emerging and existing cannabis consumer brands. The company recently completed a name and symbol change from Cascade Energy, Inc. Cannabis Strategic Ventures is publicly traded on the U.S. Over the Counter Market with the stock symbol NUGS.
FORWARD-LOOKING STATEMENTS: This release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management’s current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “would,” “could,” “will” and other words of similar meaning in connection with a discussion of future operating or financial performance.
Examples of forward-looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance.
Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company’s actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others such as, but not limited to economic conditions, changes in the laws or regulations, demand for products and services of the company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. Any forward-looking information provided in this release should be considered with these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.
Contact:
Arlene Guzman
Phone:+1-310-359-6860
Email: IR@CannabisStrategic.com
Website: http://www.CannabisStrategic.com
Corporate Communications:
NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com
Vancouver, British Columbia–(April 17, 2019) – Millennial Lithium Corp. (TSXV: ML) (the “Company”), is pleased to report an updated lithium (“Li”) and potassium (“K”) resource statement for its Pastos Grandes brine project in Salta province of Argentina. The NI 43-101 resource statement, detailed in Table 1 below, includes 4,120,000 tonnes of lithium carbonate (“Li2CO3“) equivalent (LCE) and 15,342,000 tonnes of potash (“KCl”) equivalent in the Measured and Indicated Resource categories, with an additional 798,000 tonnes ofLCEand 2,973,000 tonnes KCl in the Inferred Resource category. Compared to resource estimates completed by Montgomery & Associates in its previous report titled Measured, Indicated and Inferred Lithium and Potassium Resource Estimate Pastos Grandes Project Salta Province, Argentina and dated December 22, 2017, the updated resources represent an almost 100% increase in the Measured and Indicated LCE tonnage (2017 value of 2,131,000 tonnes LCE).
Farhad Abasov, President and CEO of Millennial Lithium, commented on the updated resources for the Pastos Grandes Project: “We are very excited to see from calculations by our hydrogeological consultants Montgomery & Associates, an approximately 100% increase in the Measured and Indicated lithium resources estimate over the 2017 Measured and Indicated Li resources. This sizable increase in our resource positions Millennial as one of the most prospective lithium brine projects in the world with the potential for a significant lithium operation. The Company now has significant Measured and Indicated lithium resources which, on the completion of ongoing studies, have the potential to be converted to Probable and Possible reserves in support of our Feasibility Study on the Company’s planned lithium carbonate processing operation. Our development work continues with the Feasibility Study and the construction of the pilot processing plant, both slated for completion in Q2.”
Table 1. Updated Pastos Grandes Brine Resource Statement
Phase II Resource
Category |
Brine Volume
(m3) |
Avg. Li
(mg/l) |
In situ Li (tonnes)* |
Li2CO3
Equivalent
(tonnes*) |
Avg. K
(mg/l) |
In situ K
(tonnes)* |
KCl Equivalent (tonnes)* |
Measured |
9.5E+08 |
446 |
425,000 |
2,262,000 |
4,734 |
4,508,000 |
8,597,000 |
Indicated |
8.6E+08 |
406 |
349,000 |
1,858,000 |
4,114 |
3,357,000 |
6,745,000 |
M+I |
1.8E+09 |
427 |
774,000 |
4,120,000 |
4,440 |
8,045,000 |
15,342,000 |
Inferred |
3.5E+08 |
428 |
150,000 |
798,000 |
4,457 |
1,559,000 |
2,973,000 |
*Cut-off Grade = 300mg/L Lithium
*Tonnages are rounded to the nearest thousand
The reader is cautioned that mineral resources are not mineral reserves and do not have demonstrated economic viability
The resource estimate was prepared in accordance with the guidelines of National Instrument 43-101 and uses best practice methods specific to brine resources, including a reliance on core drilling and sampling methods that yield depth-specific chemistry and effective (drainable) porosity measurements. The resource estimation was completed by independent qualified person Mr. Michael Rosko, M.Sc., C.P.G. of the international hydrogeology firm E.L. Montgomery and Associates (M&A).
The resource is defined over a 45 square kilometer footprint using results from rotary and core drilling and depth-specific packer sampling. In addition, the brine was also sampled during long-term (21 days) and short-term pumping (72 hours) tests. The new measured, indicated, and inferred resource was derived from geological and grade/width block models derived from 15,135 metres of core and rotary drilling. The average spacing between core holes is less than 1 km. Geophysical surveys were used to assist with location and anticipated depths for the core holes, but also to identify potential fresh water and to extend the inferred resource. Over most of the basin, the brine resource occurs to within 1 metre of surface and its thickness is defined by the extent of drilling. The maximum depth drilled was 641 metres near the center of the mining concessions, bottoming in a sandy aquifer. The deepest brine sample was obtained at a depth of 641 metres and had a Li concentration of 495 milligrams per litre.
The chemistry of the Pastos Grandes brine is judged to be very favourable. Brine density and the ratios of magnesium and sulfate to lithium are:
- Density of the brine ranges between 1.20 and 1.22 g/cm3
- Average Magnesium/Lithium ratio: 6.2
- Average Sulphate/Lithium ratio: 19.3
Based on the geologic model, approximately 76% of the brine volume in this resource is hosted by predominantly silty and sandy units and 21% by mixed halite. The balance is hosted in gravel or clay dominated units.
The total contained lithium and potassium values are based on measurements of effective (drainable) porosity distributed throughout the aquifer volume that defines this resource. This method of porosity determination is designed to estimate the portion of the total porosity that can theoretically be drained by pumping; however, these in situ estimates may differ from total extractable quantities. The porosity of the resource volume varies with geology but to date effective porosity has been predictable within distinct hydrostratigraphic units; the average for the entire saturated aquifer considered in the resource is approximately 11%.
Portions of the resource located in the clastic sediments at the margins of the salar have been demonstrated to have fresh and brackish water overlying brine. In these areas, fresh water inflow from the surface mixes with salt water in the basin; the resulting lower density fresh water and brackish fluid float on top of the more dense brine before entering the salar margins.
Resource Estimation Methodology
A total of 15,135 metres of drilling from 33 holes was evaluated for this resource estimate calculation. Other core holes and wells were drilled but were shallower. A total of 144 drainable porosity results and 311 depth-specific brine sample analyses were used in the computations, not including QA/QC samples or composite samples obtained during pumping tests. The average spacing of vertical samples for brine chemistry analysis was variable with an average of 25 metres for depth-specific brine samples. Of the 33 holes used for the resource analysis, all were terminated due to drill limitations (hydrogeologic basement was not encountered). The total thickness of the basin and the total thickness of saturated sediments are unknown. Based on drilling, additional brine-bearing aquifer material is likely to exist below 600 metres in the concession area.
The consultants chose to estimate the updated resource using Leapfrog Edge, a well-known 3-dimensional block modeling software tool. Hydrostratigraphic units have variable thickness and were determined by the consultants based on observed lithology and anticipated similar hydraulic properties.
The values for drainable porosity and grade (lithium and potassium values) for each hydrostratigraphic unit were derived from direct measured values from the well. The unit thicknesses combined with the areas yield a volume. The volumes combined with the drainable porosity values, representing the amount of fluid available from the formation yield the volume of brine. Applying the grade, represented as lithium carbonate and potassium chloride equivalents reported as weights by volume of brine then provides the estimated resource for each block, which are then summed.
The primary analytical laboratories for the data used in this resource are NORLAB in Jujuy, Argentina and SGS Laboratory in Buenos Aires, Argentina. Both laboratories are accredited to ISO 9001:2008 and ISO14001:2004 for their geochemical and environmental labs for the preparation and analysis of numerous sample types, including brines.
The porosity determinations were made by Core Laboratories of Houston, Texas and Geosystems Analysis (GSA) of Tucson, Arizona. Core Laboratories is a leading provider of proprietary and patented reservoir description, production enhancement and reservoir management services. Core Laboratories has demonstrated that its Quality Management System is in compliance with certification to ISO 9000:2008. The scope of this registration is: providing state of the art petrophysical and geological analysis and interpretation of core samples from rock. GSA has gained abundant experience since 1994 in methods used by Core Laboratories and has provided services to various other lithium projects located in Argentina and globally.
Qualified Person
The resource evaluation work was completed by Mr. Michael Rosko, M.Sc., C.P.G. of Montgomery and Associates Consultores Limitada (“M&A”). Mr. Rosko is a Registered Geologist (C.P.G.) in Arizona, California, and Texas, a Registered Member of the Society for Mining, Metallurgy and Exploration, and is a qualified person (QP) as that term is defined by NI 43-101. Mr. Rosko and hydrogeologists from M&A have been on site multiple times during the various phases of drilling and sampling operations. Mr. Rosko has extensive experience in salar environments and has been a QP on many lithium brine projects. Mr. Rosko and M&A are completely independent of Millennial Lithium. Mr. Rosko has reviewed and approved the content of this news release.
Program design and exploration support was provided by Mr. Iain Scarr, (B.Sc. – Geology, MBA, CPG) of Millennial Lithium. Mr. Scarr is a Certified Professional Geologist (CPG) with the American Association of Professional Geologists (AIPG) and a QP as defined in NI 43-101. Mr. Scarr has spent significant time on site at Pastos Grandes during all drilling and sampling operations and has extensive experience with lithium projects at other lithium bearing salars.
A Technical Report prepared under the guidelines of NI 43-101 standards describing the resource estimation will be filed on SEDAR within 45 days of this release.
To find out more about Millennial Lithium Corp. please contact Investor Relations at (604) 662-8184 or email info@millenniallithium.com.
MILLENNIAL LITHIUM CORP.
“Farhad Abasov”
President and CEO, Director
MILLENNIAL LITHIUM CORP.
1177 West Hastings Street
Suite. 2000
Vancouver, BC Canada V6E 2K3
Tel: (604) 662-8184
Fax: (604) 602-1606
E-Mail: info@millenniallithium.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This document may contain “forward-looking information” within the meaning of Canadian securities legislation (hereinafter referred to as “forward-looking statements”). All statements, other than statements of historical fact, included herein including, without limitation statements relating to the Preliminary Economic Assessment, estimated capital and operating costs, productions rates, cash flows, rates of return, mine life or mineral resources, securing of debt for future project construction, purchase of future mine production, the timing for completion of an Feasibility Study and other matters related to the exploration and development of the Project, are forward-looking statements. These forward-looking statements are made as of the date of this document and the Company does not intend, and does not assume any obligation, to update these forward-looking statements. Forward-looking statements relate to future events or future performance and reflect management’s expectations or beliefs regarding future events. By their very nature forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include unsuccessful exploration results, changes in metals prices, changes in the availability of funding for mineral exploration, unanticipated changes in key management personnel and general economic conditions, title disputes as well as those factors detailed from time to time in the Company’s interim and annual financial statements and management’s discussion and analysis of those statements, all of which are filed and available for review on SEDAR at www.sedar.com. In certain cases, forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved” or the negative of these terms or comparable terminology. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward looking statements.